5 completed, 3 recruiting, 2 active not recruiting, 1 not yet recruiting. 6 Phase 4, 2 Phase 2, 2 Phase 3, 1 Early Phase 1, 1 Phase 1.
Follow Gardasil9: new trials by email Literature Review of Gardasil9 trials Research Report on Gardasil9
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) Vaccine 10vHPV, Gardasil9 - Human Papillomavirus Infection | Phase 1 / Phase 2 | Not yet recruiting | Serum Institute of India Pvt. Ltd. | 72 | 2026-10-01 | 2026-10-22 |
| Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV Human papillomavirus (HPV) vaccine, 9-valent - Human Papilloma Virus, Anal Dysplasia | Phase 2 | Recruiting | University of Maryland, Baltimore | 120 | 2025-03-15 | 2026-08-05 |
| A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV Nonavalent HPV vaccine - HPV, Human Papilloma Virus | Phase 4 | Recruiting | University of British Columbia | 275 | 2023-07-27 | 2026-02-05 |
| Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old Gardasil9 - Human Papilloma Virus | Early Phase 1 | Active not recruiting | Boston Medical Center | 155 | 2022-09-26 | 2026-07-01 |
| Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden Gardasil9 - HPV Infection, CIN 2/3 | Phase 4 | Recruiting | Miriam Elfström | 150000 | 2021-05-03 | 2021-09-16 |
| HPV Vaccination Study in Postpartum Women Gardasil9 - HPV, Immunization | Phase 4 | Completed | Johns Hopkins University | 225 | 2020-08-03 | 2023-08-29 |
| Postpartum HPV Vaccination Gardasil9 - HPV-Related Malignancy | Phase 4 | Completed | University of Alabama at Birmingham | 195 | 2019-04-29 | 2021-10-04 |
| A Clinical Trial to Evaluate the Immunogenicity of the Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017 HPV9v - HIV Infections | Phase 4 | Completed | Fundacion SEIMC-GESIDA | 158 | 2018-10-15 | 2023-08-25 |
| Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients 9-valent HPV vaccine - Human Papilloma Virus, Hiv | Phase 3 | Completed | Universitaire Ziekenhuizen KU Leuven | 271 | 2018-04-04 | 2020-12-11 |
| Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine Human Papillomavirus 9-valent Vaccine, Recombinant - Human Papillomavirus | Phase 4 | Completed | University of British Columbia | 18 | 2017-09-11 | 2021-06-25 |
| A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls bivalent HPV vaccine, nonavalent HPV vaccine - Human Papilloma Virus | Phase 3 | Active not recruiting | London School of Hygiene and Tropical Medicine | 930 | 2017-02-23 | 2026-09-08 |
Acquired Immunodeficiency Syndrome (2) · Papillomavirus Infections (2) · Uterine Cervical Neoplasms (2) · HIV Infections (1)
University of British Columbia (2) · Boston Medical Center (1) · Fundacion SEIMC-GESIDA (1) · Johns Hopkins University (1) · London School of Hygiene and Tropical Medicine (1) · Miriam Elfström (1) · Serum Institute of India Pvt. Ltd. (1) · Universitaire Ziekenhuizen KU Leuven (1) · University of Alabama at Birmingham (1) · University of Maryland, Baltimore (1)
United States (4) · Canada (2) · Australia (1) · Belgium (1) · Spain (1) · Sweden (1) · Tanzania (1)
Betty Chou, MD (1) · Chailee Moss, MD (1) · Corinne Vandermeulen, MD, PhD (1) · Deborah Watson-Jones, Dr (1) · Elisha Wachman, MD (1) · Hitt Sharma (1) · Jenell Coleman, MD (1) · Joakim Dillner, MD, PhD (1) · Manish Sadarangani, BM BCh DPhil (1) · Omar Harfouch, MD (1) · Tobi Kollmann, MD PhD (1)
PMID 33421649, PMID 36113531, PMID 36113532, PMID 36460537, PMID 38285445, PMID 38365419, PMID 38693149, PMID 39890232, PMID 39914257, PMID 41419735, PMID 42378813